MedKoo Cat#: 596308 | Name: JTT-010

Description:

WARNING: This product is for research use only, not for human or veterinary use.

JTT-010 is a protein kinase C-beta isoform selective inhibitor.

Chemical Structure

JTT-010
JTT-010
CAS#872422-30-5

Theoretical Analysis

MedKoo Cat#: 596308

Name: JTT-010

CAS#: 872422-30-5

Chemical Formula: C23H23N3O5S

Exact Mass: 453.1358

Molecular Weight: 453.51

Elemental Analysis: C, 60.91; H, 5.11; N, 9.27; O, 17.64; S, 7.07

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
JTT-010; JTT 010; JTT010;
IUPAC/Chemical Name
(R)-3-(2-(aminomethyl)-2,3-dihydro-1H-pyrrolo[1,2-a]indol-9-yl)-4-phenyl-1H-pyrrole-2,5-dione methanesulfonate
InChi Key
KRDZHKRBOOXUIR-BTQNPOSSSA-N
InChi Code
InChI=1S/C22H19N3O2.CH4O3S/c23-11-13-10-17-19(15-8-4-5-9-16(15)25(17)12-13)20-18(21(26)24-22(20)27)14-6-2-1-3-7-14;1-5(2,3)4/h1-9,13H,10-12,23H2,(H,24,26,27);1H3,(H,2,3,4)/t13-;/m1./s1
SMILES Code
O=C(C(C1=C(C[C@H](CN)C2)N2C3=C1C=CC=C3)=C4C5=CC=CC=C5)NC4=O.CS(=O)(O)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 453.51 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Sasase T, Morinaga H, Abe T, Miyajima K, Ohta T, Shinohara M, Matsushita M, Kakehashi A. Protein kinase C beta inhibitor prevents diabetic peripheral neuropathy, but not histopathological abnormalities of retina in Spontaneously Diabetic Torii rat. Diabetes Obes Metab. 2009 Nov;11(11):1084-7. doi: 10.1111/j.1463-1326.2009.01082.x. Epub 2009 Jul 13. PubMed PMID: 19614949. 2: Tanaka M, Ubukata M, Matsuo T, Yasue K, Matsumoto K, Kajimoto Y, Ogo T, Inaba T. One-step synthesis of heteroaromatic-fused pyrrolidines via cyclopropane ring-opening reaction: application to the PKCbeta inhibitor JTT-010. Org Lett. 2007 Aug 16;9(17):3331-4. Epub 2007 Jul 26. PubMed PMID: 17655251. 3: Sasase T, Yamada H, Sakoda K, Imagawa N, Abe T, Ito M, Sagawa S, Tanaka M, Matsushita M. Novel protein kinase C-beta isoform selective inhibitor JTT-010 ameliorates both hyper- and hypoalgesia in streptozotocin- induced diabetic rats. Diabetes Obes Metab. 2005 Sep;7(5):586-94. PubMed PMID: 16050952.